Similar Articles |
|
The Motley Fool August 25, 2005 Stephen D. Simpson |
Another Cavity for Patterson Two straight disappointing quarters have drilled the medical distributor's stock. |
The Motley Fool November 23, 2005 Stephen D. Simpson |
Is It Safe for Patterson? A tougher market and high valuation don't make this dental, veterinary, and rehab supplier an especially compelling investment idea. |
The Motley Fool May 26, 2005 Stephen D. Simpson |
Patterson Gets Drilled Investors punish this dental distributor for a quarterly miss and lowered guidance. |
The Motley Fool August 25, 2011 Rich Smith |
Patterson Companies' Shares Got Crushed: What You Need to Know Shares of dental and veterinary equipment supplier Patterson Companies are looking snake-bit today, down 11% as of this writing. |
The Motley Fool November 8, 2006 Rich Duprey |
BioLase Brightens Smiles: Fool by Numbers The dental laser maker released fiscal third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool June 22, 2004 Dave Marino-Nachison |
Schein Over Europe On Friday, dental and medical products distributor Henry Schein completed the purchase of a set of European operations with roughly $340 million in sales for the fiscal year ended Sept. 30 |
The Motley Fool December 13, 2005 Stephen D. Simpson |
A Toothache at Sybron Dental Investors bail out in the wake of the company's fourth-quarter announcement. |
The Motley Fool October 31, 2005 Stephen D. Simpson |
Integra Needs to Grow From Within Acquired growth is nice, but organic growth is the key to long-term success. Quite frankly, the only way this stock works from a cash flow valuation standpoint is if the company does in fact deliver very good growth over the next 10 years or so. |
The Motley Fool August 24, 2006 Anders Bylund |
Patterson Lets the Cash Flow: Fool by Numbers Patterson Companies released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool March 3, 2004 W.D. Crotty |
Natural Food Power United Natural Foods is a healthy and growing food distributor. |
The Motley Fool March 2, 2005 Dave Marino-Nachison |
Henry Schein Shines On Trouble with partner Chiron's full vaccines hasn't stopped Henry Schein's share rise. |
The Motley Fool May 1, 2007 Rich Duprey |
Dentsply Opens Wide Strong European markets and double-digit specialty product sales boost the dental supply company. Investors, take note. |
The Motley Fool September 23, 2004 Rich Duprey |
Dentsply Is More Than a Mouthful Dental supply company increases cash dividend by 14% amid torrid growth. |
The Motley Fool March 2, 2004 Seth Jayson |
The Shine at Schein The medical supplier continues its solid growth. |
The Motley Fool April 23, 2007 Rich Duprey |
Foolish Forecast: Getting to the Root of Dentsply The dental supply company is set to report first-quarter 2007 financial results shortly. Investors, here is what you can expect to see. |
The Motley Fool July 20, 2005 Stephen D. Simpson |
Hey, Jude! Party Hearty St. Jude's ICD (implantable cardioverter defibrillator) business is on fire and fueling strong profit growth for this medical device maker. Whether your cut-off makes St. Jude a mid-cap or a large-cap, this company is certainly growing -- and the stock's valuation reflects that. |
The Motley Fool November 8, 2006 Rich Duprey |
BioLase's Reason to Smile Dental laser maker narrows loss and inks distribution deal to boost sales. The stock is a little rich at its current prices, though. Investors, take note. |
The Motley Fool October 17, 2005 Stephen D. Simpson |
A Busy Day for St. Jude In addition to announcing a major acquisition, St. Jude also reported very solid financial results for the third quarter. Analysts keep raising the bar, and the medical equipment company continues to surpass it. |
The Motley Fool April 21, 2006 Nathan Parmelee |
Intel's Inventory Mess Sales and margins down, inventories up, and some interesting spin on the conference call. In the end, Intel has enough balance sheet strength to survive, and it trades at a reasonable valuation. |
BusinessWeek May 22, 2006 Gene G. Marcial |
Why Patterson May Get Its Smile Back Analysts say the No. 2 supplier of products to dentists and dental labs in North America shows growth in sales and earnings. And its valuation makes it a prime candidate for a buyout. Investors, take note. |
The Motley Fool April 20, 2005 Stephen D. Simpson |
St. Jude's Healthy Heartbeat Medical device maker St. Jude continues to be boosted by ICD market share gains, and new businesses are coming on line, as well. |
The Motley Fool May 9, 2005 Stephen D. Simpson |
Integra LifeSciences Strikes a Nerve The med-tech company's missed quarter coupled with some slightly disappointing guidance caused investors to lose a bit of faith, sending the shares down more than 15% at one point. |
The Motley Fool February 3, 2006 Stephen D. Simpson |
Phase 2 for Intuitive Surgical Now that the initial rush is over, it's time for Intuitive Surgical to build a lasting business. Investors need to be careful with this one. |
The Motley Fool July 3, 2006 Stephen D. Simpson |
Encore Takes Final Bow Encore Medical, a med-tech company that could never quite get going, sells out to a private investor. Investors, take note. |
The Motley Fool July 18, 2008 Brian Orelli |
St. Jude Is a Fighter The medical device maker continues to kick the competition while it's down. |
The Motley Fool November 29, 2005 Stephen D. Simpson |
Organic Growth at United Natural Foods Not every number here is clean, but the story is still sweet. It's too hard to ascertain a cash flow-based valuation, however for investors who can stomach the risks, it might make a very healthy opportunity. |
The Motley Fool May 9, 2007 Rich Duprey |
BioLase's Dull Quarter The dental laser maker makes good on its promise of a disappointing quarter, but the future may be bright for investors. |
The Motley Fool October 19, 2011 Brian Orelli |
This High-Tech Company Still Has the Touch Intuitive Surgical beats analysts' expectations. Again. |
The Motley Fool January 3, 2007 Matthew Crews |
Henry Schein Herds Immunity The vaccine distributor hopes a strong 2007 will help revive its earnings. Value investors should put Henry Schein on their watch lists until it presents a greater margin of safety. |
The Motley Fool August 2, 2006 Stephen D. Simpson |
Integra the Cyborg Mediocre underlying growth is a cause for long-term concern at the med-tech company. Investors, take note. |
The Motley Fool April 19, 2006 Stephen D. Simpson |
St. Jude Lives and Learns Though dynamics in the ICD market caught it by surprise, this is still a quality med-tech company. Investors, take note. |
The Motley Fool July 27, 2005 Stephen D. Simpson |
Back Pain for Shorts? Kyphon continues to defy its skeptics. A developer of minimally invasive technology for the spine, the company saw revenue in the second quarter grow 48% as the U.S. business grew about 41% and overseas sales climbed 99%. Investors, take note. |
The Motley Fool July 27, 2006 Stephen D. Simpson |
Growth Ingrates Dump Intuitive Surgical Despite today's sell-off, Intuitive Surgical remains a red-hot grower in the med-tech space. |
The Motley Fool August 4, 2006 Stephen D. Simpson |
Patterson-UTI Fights Off the Inevitable Growing rig supply and unstable gas prices make the land drilling space riskier for investors. |
The Motley Fool October 17, 2005 Stephen D. Simpson |
A Stimulating Merger St. Jude will be paying $61.25 a share in cash for Advanced Neuromodulation Systems, a robust 30% premium to Friday's closing price. This deal demonstrates that large med-tech players may still be on the prowl for avenues into fast-growing new markets. |
The Motley Fool July 29, 2004 Rich Duprey |
Dentsply Makes Investors Smile The dental-supply company continues reporting solid profit and earnings growth. Dentsply looks as though it will continue to be a steady, consistent performer. |
The Motley Fool July 19, 2006 Stephen D. Simpson |
Taking St. Jude's Pulse The ICD market is a long-term opportunity, but not a panacea. St. Jude investors should remember that this is a rough neighborhood -- product liability, FDA bureaucracy, and huge, tough competitors live here, too. |
The Motley Fool April 17, 2008 Anders Bylund |
Foolish Forecast: Intuitive Surgical Is Worth Every Penny In advance of earnings, let's compare robotic-surgery equipment manufacturer Intuitive Surgical to some of its peers and competitors. |
The Motley Fool February 9, 2006 Stephen D. Simpson |
Dentsply: Often Overlooked, but Solid Can the dental-care company reclaim its past growth rates? Investors, take note. |
The Motley Fool July 28, 2011 Seth Jayson |
One Reason Sirona Dental Systems May Be Headed for a Slowdown Investors should check in with Sirona Dental Systems's filings to make sure there's a good reason for packing the storeroom for this period. |
The Motley Fool January 18, 2012 Dan Caplinger |
Has St. Jude Medical Become the Perfect Stock? St. Jude took a big step toward perfection when it initiated a big dividend in early 2011. |
The Motley Fool April 17, 2007 Rich Duprey |
BioLase Darkens Smiles The dental laser maker warns that quarterly revenues will be dramatically lower. Investors, take note. |
The Motley Fool August 18, 2005 Stephen D. Simpson |
Kensey Nash Needs to Kick It Up The med-tech company must deliver profit growth if it is to grow or maintain its valuation. |
The Motley Fool July 20, 2011 |
MWI Veterinary Supply Earnings Preview MWI Veterinary Supply will unveil its latest earnings Monday. |
The Motley Fool August 21, 2006 Stephen D. Simpson |
Kensey Nash Losing the Benefit of the Doubt Med-tech investors won't wait indefinitely for growth. Investors can find better values in this sector if they're willing to roll up their sleeves for some due diligence. |
The Motley Fool September 20, 2010 Anders Bylund |
This Moat Just Keeps Growing! After carving its way into our hearts and portfolios, Intuitive Surgical is still exploring many new fields. |
The Motley Fool May 9, 2006 Stephen D. Simpson |
NeuroMetrix Has a Lot of Nerve Though an excellent opportunity, the med-tech's price has outpaced value for investors. |
The Motley Fool November 23, 2005 Rick Munarriz |
Daily Double: Intuitive Surgical While growth investors may not balk at paying 69 times this year's profits for a dynamic growth company like Intuitive Surgical, they may think twice if a bottom line dip prices the company at nearly 80 times forward earnings. |
The Motley Fool January 13, 2012 Dan Caplinger |
Has Intuitive Surgical Become the Perfect Stock? What Intuitive Surgical needs to do to get even closer to perfection is to get to the point in its growth curve at which it's ready to start paying dividends. |
The Motley Fool April 22, 2005 Stephen D. Simpson |
Success Is Intuitive Surgical robotics continues to grow, and Intuitive Surgical dominates the market. It's important to note, though, that valuation is a tricky matter when you're dealing with fast-growing companies that are basically pioneering entirely new businesses. |